GlassScriptPhysician profile
Johannes Lopez
NPI 1477548204
$2,043.18
in general payments reported to CMS, 2019-2025
17 companies · $268 in 2025
The $268 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $174 · 2021: $356 · 2022: $204 · 2023: $187 · 2024: $364 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $485.47 | 2019-2025 | |
| Glaxosmithkline, LLC. | $319.02 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Cranial Technologies, INC | $261.15 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $224.83 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $171.05 | 2019-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Sanofi Pasteur INC. | $155.47 | 2019-2023 | |
| Abbvie INC. | $96.93 | 2020-2022 | |
| Genentech USA, INC. | $69.60 | 2019-2020 | |
| Phadia US INC. | $49.86 | 2020-2022 | |
| Ultragenyx Pharmaceutical INC. | $48.58 | 2021 | |
| Welch Allyn | $37.37 | 2021 | |
| Tempus Ai, INC | $28.68 | 2024 | |
| Biomarin Pharmaceutical INC. | $24.78 | 2024 | Voxzogo 1.2mg |
| Verrica Pharmaceuticals INC. | $22.94 | 2024 | Ycanth |
| Alk-Abello, INC | $17.80 | 2025 | Neffy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.37 | 2019 | |
| Tris Pharma INC | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johannes Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.